Compare BWAY & EVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWAY | EVH |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 451.2M | 468.7M |
| IPO Year | 2019 | 2015 |
| Metric | BWAY | EVH |
|---|---|---|
| Price | $25.45 | $3.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 12 |
| Target Price | ★ $26.50 | $11.17 |
| AVG Volume (30 Days) | 119.9K | ★ 2.7M |
| Earning Date | 03-10-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 213.09 | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | $49,094,000.00 | ★ $2,054,052,000.00 |
| Revenue This Year | $330.76 | N/A |
| Revenue Next Year | $22.24 | $26.87 |
| P/E Ratio | $77.54 | ★ N/A |
| Revenue Growth | ★ 27.08 | N/A |
| 52 Week Low | $7.84 | $3.50 |
| 52 Week High | $25.16 | $12.07 |
| Indicator | BWAY | EVH |
|---|---|---|
| Relative Strength Index (RSI) | 70.20 | 29.07 |
| Support Level | $22.90 | $3.68 |
| Resistance Level | $24.78 | $4.06 |
| Average True Range (ATR) | 1.23 | 0.22 |
| MACD | 0.07 | -0.03 |
| Stochastic Oscillator | 95.76 | 1.06 |
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.